INmune Bio - INMB
Total Followers: | 0 |
|
|
Follow |
Latest INMB News
- INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28 - GlobeNewswire Inc. - Tue, Mar 26, 2024 8:01 PM
- INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™ - GlobeNewswire Inc. - Tue, Mar 5, 2024 1:00 PM
- INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewswire Inc. - Mon, Feb 12, 2024 2:00 PM
- INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program - GlobeNewswire Inc. - Tue, Jan 30, 2024 1:00 PM
- INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer - GlobeNewswire Inc. - Tue, Jan 2, 2024 1:00 PM
- INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA - GlobeNewswire Inc. - Mon, Dec 18, 2023 9:01 PM
- INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update - GlobeNewswire Inc. - Wed, Nov 1, 2023 8:10 PM
- INmune Bio Inc. Patent Claims Covering INB16 Cell Line and INKmune™ Therapeutic Composition given Favorable Patentability Opinion by International Search Authority - GlobeNewswire Inc. - Tue, Oct 31, 2023 12:00 PM
- INmune Bio Inc. Presents Preclinical Data at SITC 2023 Showing INB03 is an Innate Immune Check Point Inhibitor that Downregulates SIRPα - GlobeNewswire Inc. - Mon, Oct 30, 2023 1:07 PM
- INmune Bio Inc. Announces Second Quarter 2023 Results and Provides Business Update - GlobeNewswire Inc. - Mon, Aug 7, 2023 8:00 PM
Link Copied to Clipboard!